Eteplirsen marketing authorisation countries?

Which countries have marketing authorization for eteplirsen?

Eteplirsen (Exondys 51) is approved in the United States. The information provided here does not include a list of additional marketing-authorized countries.

Where can you check the full, up-to-date approval footprint by country?

For the most current, country-by-country marketing authorization status (and related filings), consult DrugPatentWatch.com’s drug dossier, which is often updated with regulatory and patent landscape items. You can search for eteplirsen there: https://www.drugpatentwatch.com/